Skip to content
MyFXHero

Concept in development · Not a live platform

The MyFXHero Battlefield.

Battlefield is the next chapter of MyFXHero: a multi-broker environment where providers, investors and broker partners meet around structured, comparable trading — rather than screenshots and unverifiable claims.

Pre-launch notice

MyFXHero Battlefield is a concept in development. Nothing described here is a live product, a performance claim, an investment offer or a managed account service. Features and availability may change.

The concept

What Battlefield is being built to do.

Four ideas define the direction. Everything below describes intent, not shipped software.

Multi-broker battlefield

A shared environment where traders participate across different brokers under comparable, clearly stated conditions instead of isolated screenshots.

Provider discovery

A structured way for trade-idea providers to be found by an audience that cares about method and consistency, not just short-term numbers.

Investor access

A place for interested followers to review participants by structure, approach and stated risk framework before deciding what to follow.

Structured strategy comparison

Comparable presentation of approach, instruments, risk parameters and execution style — so like is compared with like.

Roadmap

A deliberate sequence.

  1. Phase 1 — Today

    Execution tooling for gold traders and partner broker access. Live now.

  2. Phase 2 — Battlefield preview

    Concept validation, waitlist segmentation and early participant onboarding.

  3. Phase 3 — Battlefield

    Provider profiles, investor discovery and structured comparison across broker partners.

Early access

Join the Battlefield waitlist

Register your interest and we will contact you when early access opens. No commitment, no fees, no product is being sold here.

I am joining as

By joining you agree to be contacted about MyFXHero Battlefield. Battlefield is a concept in development — no live platform, no performance claim and no investment offer.